Introduction
Metronidazoleis an antibiotic and useful against the diseases caused by the anaerobic bacteria and some of the parasites. It selectively blocks nucleic acid synthesis by disrupting the DNA of microbial cells and the parasites resulting in their death. It has the relatively little effect on human cells or aerobic bacteria, but this function only occurs in anaerobic cells [1, 2] . It is used to treat bacterial infections in vagina (trichomoniasis), stomach infections (pseudomembranous colitis, giardiasis), liver, skin, joints (pelvic inflammatory disease, abscess of the ovaries and fallopian tubes), brain, and respiratory tract, aspiration pneumonia, fungating wounds, rosacea, intraabdominal infections, lung abscess, periodontitis, amoebiasis, oral infections, and other infections caused by the anaerobic organisms such as Bacteroides, Clostridium, Helicobacter pylori, Fusobacterium, Dracunculus, Peptostreptococcus, and Prevotella species, etc. [2] [3] [4] [5] . It is also used for the treatment of infections caused by Giardia in domestic
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progressive relaxation, relaxation techniques, guided imagery, acupuncture, acupressure, movement therapy, hypnotherapy, pilates, Rolfing structural integration, mindfulness, cranial sacral therapy, aromatherapy, and applied prayer. The CAM has been accepted by the most of the U.S. population because of many advantages [20, 21] . The Trivedi Effect®-Consciousness Energy Healing Treatment has huge potential to alter the physicochemical, structural, and behavioral properties of organic compounds, metals, polymers, ceramics [22] [23] [24] [25] [26] , inhibition of the microorganisms [27, 28] , kill cancer cells [29, 30] , and also improve the overall productivity of crops [31, 32] . Seeing all these surprising results, this study was designed to evaluate the impact of the Trivedi Effect®-Consciousness Energy Healing Treatment on the physicochemical, thermal, and behavioral properties of metronidazole powder sample using Particle Size Analysis (PSA), Powder X-Ray Diffraction (PXRD), Differential Scanning Calorimetry (DSC), and Thermogravimetric Analysis (TGA)/Differential Thermogravimetric Analysis (DTG).
Materials and Methods

Chemicals and reagents
Metronidazole
(2-Methyl-5-nitroimidazole-1-ethanol) was purchased from Tokyo Chemical Industry Co., Ltd., Japan. All other chemicals used during the experiments were of analytical grade available in India.
Consciousness energy healing treatment strategies
Metronidazole considered as the test sample for the experiment was divided into two equal parts. One part of the test sample was treated with the Trivedi Effect®-Consciousness Energy Healing Treatment remotely under standard laboratory conditions for 3 minutes and known as the Biofield Energy Treated sample. This Biofield Energy Treatment was provided through the healer's unique energy transmission process by the renowned Biofield Energy Healer, Dahryn Trivedi, USA, to the sample of metronidazole. However, the second part of the test sample was termed as a control sample (no Biofield Energy Treatment was provided). Further, the control sample was treated with a "sham" healer for the comparison purpose. The "sham" healer did not have any knowledge about the Biofield Energy Treatment. After treatment, the Biofield Energy Treated and untreated samples were both kept in sealed conditions for the characterization using PSA, PXRD, DSC, and TGA techniques.
Characterization
Particle size analysis (PSA): The PSA of metronidazole powder sample was conducted on Malvern Mastersizer 2000, from the UK with a detection range between 0.01 µm to 3000 µm using wet method [33, 34] . The sample unit (Hydro MV) was filled with a dispersant medium (sunflower oil) and the stirrer operated at 2500 rpm. The PSA analysis of metronidazole powder sample was performed to obtain the average particle size distribution. Where d(0.1) μm, d(0.5) μm, d(0.9) μm represent particle diameter corresponding to 10%, 50%, and 90% of the cumulative distribution. D(4,3) represents the average mass-volume diameter, and SSA is the specific surface area (m 
Powder X-ray diffraction (PXRD) analysis:
The PXRD analysis of metronidazole powder sample was performed with the help of Rigaku MiniFlex-II Desktop X-ray diffractometer (Japan) [35, 36] . The Cu Kα radiation source tube output voltage used was 30 kV, and tube output current were 15 mA. Scans were performed at room temperature. The average size of individual crystallites was calculated from PXRD data using the Scherrer's formula
Where k is the equipment constant (0.94), G is the crystallite size in nm, λ is the radiation wavelength (0.154056 nm for Kα1 emission), β is the full-width at half maximum (FWHM), and θ is the Bragg angle [37] .
The percent change in crystallite size (G) of metronidazolewas calculated using the following equation 3:
Where G Control and G Treated are the crystallite size of the control and the Biofield Energy Treated samples, respectively.
Differential scanning calorimetry (DSC):
The DSC analysis of metronidazole powder sample was performed with the help of DSC Q200, TA instruments. A sample of ~1-3 mg was loaded into the aluminium sample pan at a heating rate of 10 ºC/min from 30 °C to 350 °C [33, 34] . The % change in melting point (T) was calculated using the following equation 4: Where ΔH Control and ΔH Treated are the latent heat of fusion of the control and the Biofield Energy Treated metronidazole, respectively. Thermal gravimetric analysis (TGA)/ Differential thermogravimetric analysis (DTG): TGA/DTG thermo grams of metronidazole powder sample were obtained with the help of TGA Q50TA instruments. The sample of ~3-6 mg was loaded to the platinum crucible at a heating rate of 10 ºC/min from 25 °C to 1000 °C with the recent literature [33, 34] . The % change in Weight loss (W) was calculated using the following equation 6:
Where W Control and W Treated are the weight loss of the control and the Biofield Energy Treated metronidazole powder sample, respectively.
The % change in maximum thermal degradation temperature (T max ) (M) was calculated using the following equation 7:
Where M Control and M Treated are the T max values of the control and the Biofield Energy Treated metronidazole powder sample, respectively.
Results and Discussion
Particle size analysis (PSA)
The particle size analysis of both the control and the Biofield Energy Treated metronidazole powder samples were performed, and the calculated data are presented in Table 1 and D(4,3) , respectively compared to the control sample. The specific surface area of the Biofield Energy Treated metronidazole powder (0.0262 m 2 /g) was significantly decreased by 10.58% compared to the control sample (0.0262 m 2 /g). It can be presumed that the Trivedi Effect®-Consciousness Energy Healing Treatment might be responsible for increasing the smaller particles to larger particles of metronidazole powder sample, thus decreasing the surface area. It was reported that the particle size, shape, and surface area impact the powder flow ability, stability, solubility, dissolution rate, absorption, bioavailability, and therapeutic efficacy of a drug [38, 39] . Thus, it was expected that the Biofield Energy Treated metronidazole sample might offer better powder flow ability, good stability, and rapid dissolving rate compared to the control sample. 
Powder X-ray diffraction (PXRD) analysis
The PXRD diffractogram of the control metronidazole powder sample shown sharp and intense peaks at Bragg's angle (2θ) equal to 6.29°, 12.28°, 13 (Figure 1) . The sharp and intense peaks in the diffractograms indicated that both the samples were crystalline. The control and the Biofield Energy Treated sample showed the highest peak intensity at 2θ equal to 12.28° and 12.64°, respectively (Table 2, entry 2). The peak intensities of the Biofield Energy Treated metronidazole were significantly altered ranging from -97.25% to 401.64% compared to the control sample. Likewise, the crystallite sizes of the Biofield Energy Treated metronidazole powder sample were significantly altered ranging from -63.08% to 344.35% compared to the control sample. Hence, the average crystallite size of the Biofield Energy Treated metronidazole powder sample (423.47 nm) was significantly increased by 24.4% compared to the control sample (340.41 nm).
The alteration in the crystallite sizes and peak intensities indicated the change in the crystal morphology of the Biofield Energy Treated metronidazole powder compared to the control sample. The peak intensity of each diffraction face on the crystalline compound changes according to the crystal morphology and alterations in the XRD pattern provide proof of polymorphic transitions [40] [41] [42] . The Trivedi Effect®-Consciousness Energy Healing Treatment probably responsible for the production of a new polymorphic form of metronidazole through the mediation of neutrino oscillations [18] . Altered polymorphic forms of pharmaceuticals have a significant effect on the drug performance, such as bioavailability, therapeutic efficacy, and toxicity, because of their different thermodynamic and physicochemical properties from the original one [43] . Hence, it can be assumed that the Biofield Energy Treated metronidazole would be better in designing more effective pharmaceutical formulations.
Differential scanning calorimetry (DSC) analysis
The thermograms of the control and the Biofield Energy Treated metronidazole samples showed the sharp endothermic peak at 161.48 °C and 161.22 °C, respectively (Figure 2) . Similarly, both the control and the Biofield Energy Treated samples showed exothermic peaks at 287.52 °C and 288.13 °C, respectively (Figure 2 ). The experimental data closely matched to the literature reported data [10] . The melting point and decomposition temperature of the Biofield Energy Treated samples were altered by -0.16% and 0.21%, respectively compared with the control sample ( Table 3 ). The latent heat of fusion (∆H fusion ) and latent heat of decomposition (∆H decomposition ) of the Biofield Energy Treated metronidazole were significantly increased by 7.64% and 12.13% compared with the control sample ( Table 3 ). The melting point has been reported to increase with increasing particle size [44, 45] . The particle size data justified the decreased thermal properties of the Biofield Energy Treated metronidazole compared to the control sample. As per the literature, any change in the latent heat of fusion can be attributed to the disrupted molecular chains and the crystal structure [46] . Thus, it can be assumed that the Trivedi Effect®-Consciousness Energy Healing Treatment might have altered the molecular chains and crystal structure of the Biofield Energy Treated metronidazole molecule so that the thermal stability of the treated sample was increased compared with the control sample.
Thermal gravimetric analysis (TGA)/ Differential thermogravimetric analysis (DTG)
The control and the Biofield Energy Treated samples showed one step of thermal degradation in the TGA thermograms ( Figure 3 ). The total weight loss of the Biofield Energy Treated metronidazole sample was decreased by 1.34% more compared to the control sample (Table  4) . Therefore, the residue amount was significantly increased by 76.46% in the Biofield Energy Treated sample compared to the control sample ( Table 4 ).
The DTG thermograms of the control and the Biofield Energy Treated sample also showed one peak in the thermograms ( Figure  4 ). The maximum thermal degradation temperature (T max ) of the Biofield Energy Treated sample was decreased by 2.94% compared to the control sample (Table 4) . Hence, the overall TGA/DTG results of metronidazole powder samples revealed that the thermal stability of the Biofield Energy Treated sample was increased compared to the control sample.
Conclusion
The Trivedi Effect®-Consciousness Energy Healing Treatment has shown a significant effect on the particle size, surface area, crystallite size, and thermal properties of metronidazole. The particle size values in the Biofield Energy Treated metronidazole powder sample were significantly increased by 14.37%, 9.94%, 7.9%, and 9.41% at d 10 , d 50 , d 90 , and D(4,3) compared to the control sample. Therefore, the specific surface area of the Biofield Energy Treated powder sample was significantly decreased by 10.58% compared to the control sample. The PXRD peak intensities and crystallite sizes of the Biofield Energy Treated powder sample were significantly altered ranging from -97.25% to 401.64% and -63.08% to 344.35%, respectively compared to the control sample. The average crystallite size of the Biofield Energy Treated metronidazole powder was significantly increased by 24.4% compared with the control sample. The melting and decomposition temperature of the Biofield Energy Treated sample slightly altered compared with the control sample. However, the ∆H fusion and ∆H decomposition were significantly increased by 7.64% and 12.13% in the treated sample compared with the control sample. The total weight loss was decreased by 1.34%; however, the residue amount was significantly increased by 76.46% in the treated sample compared with the control sample. The T max was altered by 2.94% in the treated sample compared with the control sample. Therefore, the 
